Travere Therapeutics, Inc. TVTX
- FILSPARI — IgA Nephropathy Approved
- FILSPARI — Focal Segmental Glomerulosclerosis Approved
Home › Targets › angiotensin II
angiotensin II (1 companies · 2 programs)
Companies with an active program directed at angiotensin II.